OHRS News - DF/HCC Multi-Center Research and The NIH sIRB Mandate

February 07, 2018

DF/HCC Multi-Center Research and The NIH sIRB Mandate:

On January 25, 2018, the NIH Policy on the use of a single IRB for Multi-site research went into effect.  From now on, it is the expectation that multi-site studies conducting the same protocol will use a Single IRB to carry out the ethical review of the proposed research.  https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-094.html

For more information and guidance see resources on the Office for Human Research Studies (OHRS) website:

Information Sheet (IS) covering the DF/HCC Consortium, the DFCI IRB   and the NIH sIRB Rule.   This document will help DF/HCC Investigators determine whether the DFCI IRB will serve as the IRB of Record or not, and when reliance on an External sIRB will be required.

Frequently Asked Questions (FAQ) IS for DF/HCC Investigators to help with questions related to the new NIH sIRB rule.

http://www.dfhcc.harvard.edu/research/clinical-research-support/office-for-human-research-studies/single-irb/

Questions?

Please do not hesitate to contact OHRS staff:

http://www.dfhcc.harvard.edu/research/clinical-research-support/office-for-human-research-studies/ohrs-contact-list/

 

Office for Human Research Studies
Dana-Farber Cancer Institute
450 Brookline Ave., OS229
Boston, MA 02215
Phone: 617-632-3029
Pager: 42299
OHRS@dfci.harvard.edu
www.dfhcc.harvard.edu/ohrs